Read + Share
Afroz T, Chevalier E, Audrain M, Dumayne C, et al. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology
and confers neuroprotection in mouse models of ALS/FTD. Neurobiol Dis 2023;179:106050.
PMID: 36809847
|
 |
|
Afroz T, Chevalier E, Audrain M, Dumayne C, et al. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology
and confers neuroprotection in mouse models of ALS/FTD. Neurobiol Dis 2023;179:106050.
PMID: 36809847
|
|
|
|